Home Stock

Stock Research: Pacira BioSciences

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Pacira BioSciences

NasdaqGS:PCRX US6951271005
72
  • Value
    77
  • Growth
    78
  • Safety
    Safety
    86
  • Combined
    100
  • Sentiment
    6
  • 360° View
    360° View
    72
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Pacira BioSciences is a pharmaceutical company specializing in non-opioid treatments for pain management. The company operates in the pharmaceutical industry, with key products including EXPAREL, ZILRETTA, and iovera. Pacira BioSciences operates in the US. In the last fiscal year, the company had 790 employees, a market cap of $1,060 million, profits of $531 million, and revenue of $701 million.

more
Strongest Rank Dividend Yield
Weakest Rank Capital Growth
Country USA
Industry Pharmaceuticals
Size Small
Website pacira.com
Index
NASDAQ
D.J. US Pharmaceutical
Pacira BioSciences stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
77 74 49 29
Growth
78 67 79 65
Safety
Safety
86 79 58 61
Sentiment
6 44 75 30
360° View
360° View
72 91 91 40
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
7 11 64 43
Opinions Change
50 82 50 11
Pro Holdings
n/a 82 63 61
Market Pulse
31 19 63 70
Sentiment
6 44 75 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
77 74 49 29
Growth
78 67 79 65
Safety Safety
86 79 58 61
Combined
100 100 81 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
83 90 75 63
Price vs. Earnings (P/E)
74 57 46 30
Price vs. Book (P/B)
65 61 50 38
Dividend Yield
1 1 1 1
Value
77 74 49 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
63 54 64 69
Profit Growth
28 43 60 71
Capital Growth
100 94 78 31
Stock Returns
59 39 47 55
Growth
78 67 79 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
44 49 36 42
Refinancing
75 67 59 51
Liquidity
72 66 64 65
Safety Safety
86 79 58 61

Similar Stocks

Discover high‑ranked alternatives to Pacira BioSciences and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews